Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 5/20 | 0.52 |
| ▸ | CES2 | O00748 | 4/20 | 0.52 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.50 |
| ▸ | PPARG | P37231 | 7/20 | 0.50 |
| ▸ | PPARD | Q03181 | 7/20 | 0.50 |
| ▸ | PPARA | Q07869 | 7/20 | 0.50 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.50 |
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TLR2 | O60603 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | FABP4 | P15090 | 2/20 | 0.50 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.50 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | ESR1 | P03372 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | PDE4A | P27815 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29245554 | 1.00 | CES1 (0.52) | CES1CES2GPR84PPARGPPARD | |
| SCHEMBL29245616 | 1.00 | CES1 (0.52) | CES1CES2GPR84PPARGPPARD | |
| Hydrochloric Acid SCHEMBL28803592 | 0.98 | CES1 (0.50) | CES1CES2GPR84PPARGPPARD | |
| Ethylene Glycol SCHEMBL17984101 | 0.94 | CES1 (0.46) | CES1CES2GPR84PPARGPPARD | |
| SCHEMBL8848803 | 0.93 | CES2 (0.54) | CES1CES2GPR84PPARGPPARD | |
| SCHEMBL11105644 | 0.93 | CES2 (0.54) | CES1CES2GPR84PPARGPPARD | |
| SCHEMBL13065188 | 0.91 | CES2 (0.52) | CES1CES2GPR84PPARGPPARD | |
| SCHEMBL30615749 | 0.89 | EPHX2 (0.60) | CES1PPARGPPARDPPARAPTPN1 | |
| SCHEMBL28262589 | 0.88 | CES2 (0.45) | CES1CES2GPR84PPARGPPARD | |
| SCHEMBL6120073 | 0.87 | CES2 (0.48) | CES1CES2GPR84PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250319035-A1 | CATIONIC LIPID NANOPARTICLE HAVING HIGH TRANSFECTION EFFICIENCY AND PREPARATION METHOD THEREFOR | TONG, Shuwen (CN) | 2025-10-16 | — | — | US | claimed |
| CN-119365189-A | Cationic lipid nanoparticle with high transfection efficiency and preparation method thereof | 北京多纳医药科技有限公司 | 2025-01-24 | — | — | CN | claimed |
| US-20250319035-A1 | CATIONIC LIPID NANOPARTICLE HAVING HIGH TRANSFECTION EFFICIENCY AND PREPARATION METHOD THEREFOR | TONG, Shuwen (CN) | 2025-10-16 | — | — | US | disclosed |
| CN-119896747-A | Calcium-containing lipid nanoparticle loaded with transthyretin nucleic acid for reducing transthyretin | 苏州多纳医药科技有限公司 | 2025-04-29 | — | — | CN | disclosed |
| CN-119365189-A | Cationic lipid nanoparticle with high transfection efficiency and preparation method thereof | 北京多纳医药科技有限公司 | 2025-01-24 | — | — | CN | disclosed |
| WO-2023208076-A1 | CATIONIC LIPID NANOPARTICLE HAVING HIGH TRANSFECTION EFFICIENCY AND PREPARATION METHOD THEREFOR | 北京多纳医药科技有限公司 | 2023-11-02 | — | — | WO | disclosed |
| CN-116348084-A | Cosmetic compositions, kits, and methods of making and using the same | 莱雅公司 | 2023-06-27 | — | — | CN | disclosed |
| CN-116018127-A | Cosmetic compositions, kits, and methods of making and using the same | 莱雅公司 | 2023-04-25 | — | — | CN | disclosed |
| CN-113301965-A | Hair care system, hair care method and use of hair care system | 欧莱雅 | 2021-08-24 | — | — | CN | disclosed |
| CN-113271917-A | Hair care and conditioning composition | 莱雅公司 | 2021-08-17 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250319035-A1 | CATIONIC LIPID NANOPARTICLE HAVING HIGH TRANSFECTION EFFICIENCY AND PREPARATION METHOD THEREFOR | CETP, NPC1L1, LIPA | CES1 78/4885CES2 945/4885GPR84 3916/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.